Darwin Global Management, Ltd. Aclaris Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

  • $1.23 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $2.11 Million - $3.87 Million
-216,143 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $696,322 - $1.05 Million
56,750 Added 35.6%
216,143 $3.14 Million
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $1.21 Million - $1.7 Million
-90,607 Reduced 36.24%
159,393 $2.87 Million
Q2 2021

Aug 16, 2021
BUY
$17.08 - $29.6 $4.27 Million - $7.4 Million
250,000 New
250,000 $4.39 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $242M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email